To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at For Technical questions please contact Thank you.

Leukemia p53 Hotspot Mutation Cell Panel (ATCC® TCP-2070)

Organism: Homo sapiens, human  / 

Permits and Restrictions

View Permits

Organism Homo sapiens, human
Components CESS, ATCC TIB-190
HL-60, ATCC CCL-240
ARH-77, ATCC CRL-1621
Applications Biological understanding of top genetic alterations in leukemia
Novel anti-cancer drug targeting
Reactivation of mutant p53
Studies related to p53 molecular mechanisms
Testing small molecules or biologics for cancer drug development
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Leukemia p53 Hotspot Mutation Cell Panel is composed of six select suspension cell lines derived from individuals with leukemia. The mutations have been sequenced and validated by ATCC. This panel includes p53 wild type cell lines as well as p53 mutant lines that carry hotspot mutations in one of the following codons: 175, 248 and 273.
Product Format frozen
Storage Conditions liquid nitrogen vapor phase
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Other Documentation